Compound information
- Natural Products
- ZC1561620
- Molecular Formula
- C15H21BrN2O4S
- Molecular Weight
- 404.040540252 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-bromophenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H21BrN2O4S/c1-15(2,3)22-14(19)17-8-10-18(11-9-17)23(20,21)13-6-4-12(16)5-7-13/h4-7H,8-11H2,1-3H3
- InChI Key
- AQKVPXFKSGCQHL-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1
- Source
- ZINC000040456674
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.126 |
LogS | -4.175 | LogD | 3.715 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.058 | Pgp substrate | 0.011 |
HIA | 0.974 | F20 % | 0.994 |
F30 % | 0.975 | Caco-2 | -4.381 |
MDCK | -4.864 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.893 | PPB | 95.826 |
VD | 1.997 | Fu | 0.747 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.093 | CYP1A2 substrate | 0.485 |
CYP2A6 substrate | 0.633 | CYP2B6 substrate | 0.658 |
CYP2C19 inhibitor | 0.944 | CYP2C19 substrate | 0.843 |
CYP2C8 substrate | 0.662 | CYP2C9 inhibitor | 0.749 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.116 |
CYP2D6 substrate | 0.881 | CYP2E1 substrate | 0.902 |
CYP3A4 inhibitor | 0.161 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.286 | CL | 6.446 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.82 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.32 | Rat Oral Acute Toxicity | 0.335 |
FDAMDD | 0.123 | Skin Sensitization | 0.081 |
Carcinogenicity | 0.965 | Eye Corrosion | 0.132 |
Eye Irritation | 0.081 | Respiratory Toxicity | 0.636 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.713 | IGC50 | 3.521 |
LC50FM | 2.977 | LC50DM | 4.049 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.192 | NR-AR-LBD | 0.288 |
NR-AhR | 0.029 | NR-Aromatase | 0.324 |
NR-ER | 0.237 | NR-ER-LBD | 0.399 |
NR-PPAR-gamma | 0.125 | SR-ARE | 0.75 |
SR-ATAD5 | 0.38 | SR-HSE | 0.087 |
SR-MMP | 0.028 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.